U

Uromems

Company profile · headcount, org chart & B2B contacts

8 Decision makers
200 Employees
$7M Revenue
2011 Founded

Organizational Chart of Uromems

Roles identified within Uromems's leadership team, based on public professional data.

Department

Uromems's Full Organizational Chart

Loading…

Get their contacts on Zeliq →

Job title Department People Action

Decision-maker contacts at Uromems

Unlock emails & phones →

Decision makers at Uromems

8 identified 5 C-Level 3 Directors
See them on Zeliq →

Funding

Last round Venture · $60M
Total funding $151M (12 rounds)
Corporate Round N/A Jul 2011
Series A $13M Nov 2016
Grant $2M Nov 2016
Series B $18M May 2020
Debt Financing N/A May 2020
Series B $8M Apr 2021
Venture Round N/A Jun 2023
Grant $2M Jun 2023
Grant N/A Oct 2023
Series C $47M Jun 2024
Venture Round $60M May 2026
Venture Round N/A

Team Structure headcount by department

Technical
24
Other
11
Medical
7
Project Management
6
Finance
5
Operations
5
General Management
4
Research
3

Companies similar to Uromems

More companies to explore

Biotechnology Research · France

All Biotechnology Research companies in France →

About Uromems

Uromems is a Biotechnology Research company, operating from France. Founded in 2011, the company employs approximately 200 people. Uromems belongs to the Professional Services sector, with a specific positioning on Biotechnology Research. Its customer base is mainly professional: Uromems operates on a B2B model. The company has secured 12 rounds of funding totalling $151M. The company generates approximately $7M in annual revenue. Use this page to review Uromems's industry, headcount, location and hiring signals, and to reach verified B2B contacts before your next outreach.

Activity & Market

The company evolves in the Biotechnology Research segment of the Professional Services sector. As a B2B company, Uromems primarily serves business clients and professional organisations. The company is categorised as “Privately held”.

How to prospect Uromems's departments

Technical

This is where the company's largest headcount sits (24 people). Technical teams verify claims: public docs, a sandbox or a free tier will do the selling for you.

Other

With 11 people, this is the organisation's second pillar. Mixed profiles gather here: a discovery-first approach works better than a packaged pitch.

Medical

7 people work in this department. Medical teams trust peer references: name comparable organisations you already serve.

Project Management

A team of 6 people. Methodology debates are constant here: anchor your pitch in their existing framework rather than against it.

Finance

This department counts 5 people. Build your pitch around ROI, payback period and risk reduction: the language this department speaks.

Operations

5 people work in this department. Operations leaders live in the concrete: a pilot scoped on one process will convince more than a demo.

FAQ Uromems

What industry does Uromems operate in?

Uromems operates in the Biotechnology Research industry, specifically in the Professional Services category.

How many employees does Uromems have?

Uromems has approximately 200 employees (in the 51-200 range). This figure is an estimate to help qualify the account, not a legally certified number.

How do I find contacts at Uromems?

With Zeliq, you can find the right decision makers at Uromems, get their verified emails and direct phone numbers, and engage them through targeted multichannel sequences.

Where is Uromems headquartered?

Uromems is headquartered in France.

What is the organizational chart of Uromems?

Roles identified within Uromems's organization include COO, CFO, Directeur Développement de Logiciels, Industrialization Project Leader, Human Resources Business Partner. With Zeliq, you can enrich each of these roles with verified emails and direct phone numbers.

Why use this data before prospecting Uromems?

Knowing Uromems's industry, headcount, and business signals lets you personalise your outreach, prioritise high-potential accounts, and reach the right decision makers from the very first contact.